Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

← catalyst calendar

NCT02071134 · readout ≤ 4,516 d

Sponsored by Boston Scientific Corporation (industry) · BSX — their whole pipeline →.

Phase

—

Status

Recruiting

Study type

Observational

Enrollment

1,500estimated

Sites

Countries

Argentina, Austria, Belgium +12

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis

Date

Filed

Basis

What it is

Start

2014-03-04

actual

When the study began enrolling

Primary completion

Dec 2038

estimated

The date the last participant is measured for the primary outcome — the readout window

Study completion

Dec 2038

estimated

The whole study's end, after follow-up

First posted

2014-02-25

estimated

When this record first appeared on the registry

Results posted

—

When the sponsor posted results to the registry

Record updated

2026-08-11

actual

The sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

Parkinson's Disease

Intervention

Device: Deep Brain Stimulation (DBS) — also filed as Vercise DBS System, Boston Scientific

Primary outcome

what the primary-completion date above is the date OF

Improvement in patient's quality of life (QoL) during the study as compared with baseline

measured up to 3 years

Permalink · BSX's whole pipeline · Catalyst calendar · Every registered study · What changed